LMAT Earnings & Financial Statements
LeMaitre Vascular, Inc.
$83.16
+$0.54(+0.65%)
56
Overall
75
Value
30
Tech
65
Quality
Market Cap
$1.89B
Volume
297.90K
52W Range
$78.22 - $118.01
Target Price
$107.43
LMAT earnings and financial statements: LeMaitre Vascular, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
LMAT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $249.60M | $219.86M | $193.48M | $161.65M | $154.42M |
| Cost of revenue | $71.06M | $68.96M | $66.44M | $56.76M | $53.04M |
| Operating income | $67.91M | $52.26M | $36.71M | $26.83M | $36.42M |
| EBITDA | $91.66M | $66.75M | $48.99M | $36.92M | $47.58M |
| Net income | $57.73M | $44.04M | $30.11M | $20.64M | $26.91M |
| EPS (diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $615.69M | $551.82M | $346.78M | $310.48M | $292.80M |
| Total liabilities | $222.17M | $214.53M | $48.88M | $42.27M | $38.65M |
| Shareholders’ equity | $393.52M | $337.29M | $297.90M | $268.20M | $254.15M |
| Cash and equivalents | $28.24M | $25.61M | $24.27M | $19.13M | $13.86M |
| Long-term debt | $182.65M | $183.00M | $16.62M | $14.71M | $14.07M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $81.25M | $44.12M | $36.75M | $25.38M | $35.10M |
| Capital expenditure | -$6.78M | -$6.96M | -$7.26M | -$3.23M | -$4.88M |
| Free cash flow | $74.47M | $37.16M | $29.49M | $22.15M | $30.22M |
| Dividends paid | $18.11M | $14.38M | $12.45M | $10.99M | $9.34M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LMAT | $83.16 | +0.7% | 297.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |